ADT-094 suppresses tumor cell growth by inhibiting PDE5 and 10 to activate cGMP/PKG signaling, leading to the disruption of β-catenin/TCF transcriptional activity and the synthesis of critical proteins required for the proliferation and survival of tumor cells. The gene discussed is PRKG1; the disease is neoplasm.